- Home
- TBNK vs AVTX Comparison
TBNK vs AVTX Comparison
Compare TBNK & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBNK
- AVTX
- Stock Information
- Founded
- TBNK 1921
- AVTX 2011
- Country
- TBNK United States
- AVTX United States
- Employees
- TBNK N/A
- AVTX N/A
- Industry
- TBNK Savings Institutions
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- TBNK Finance
- AVTX Health Care
- Exchange
- TBNK Nasdaq
- AVTX Nasdaq
- Market Cap
- TBNK 83.2M
- AVTX 90.9M
- IPO Year
- TBNK N/A
- AVTX 2015
- Fundamental
- Price
- TBNK $10.35
- AVTX $9.54
- Analyst Decision
- TBNK Hold
- AVTX Buy
- Analyst Count
- TBNK 2
- AVTX 3
- Target Price
- TBNK $9.89
- AVTX $29.50
- AVG Volume (30 Days)
- TBNK 14.0K
- AVTX 90.5K
- Earning Date
- TBNK 01-24-2025
- AVTX 11-07-2024
- Dividend Yield
- TBNK 0.38%
- AVTX N/A
- EPS Growth
- TBNK N/A
- AVTX N/A
- EPS
- TBNK N/A
- AVTX N/A
- Revenue
- TBNK $36,203,000.00
- AVTX $820,000.00
- Revenue This Year
- TBNK N/A
- AVTX N/A
- Revenue Next Year
- TBNK $8.07
- AVTX N/A
- P/E Ratio
- TBNK N/A
- AVTX N/A
- Revenue Growth
- TBNK N/A
- AVTX N/A
- 52 Week Low
- TBNK $6.92
- AVTX $3.95
- 52 Week High
- TBNK $11.64
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- TBNK 41.80
- AVTX 42.72
- Support Level
- TBNK $10.40
- AVTX $9.00
- Resistance Level
- TBNK $10.78
- AVTX $9.82
- Average True Range (ATR)
- TBNK 0.22
- AVTX 0.75
- MACD
- TBNK -0.03
- AVTX 0.01
- Stochastic Oscillator
- TBNK 0.00
- AVTX 27.86
About TBNK Territorial Bancorp Inc.
Territorial Bancorp Inc operates as a bank holding company. It offers a wide variety of FDIC-insured deposit products and loan products for the consumer and small businesses. Its business consists of accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in one-to-four-family residential mortgage loans and investment securities. The company offers a variety of deposit accounts, including passbook and statement savings accounts, certificates of deposit, money market accounts, commercial and regular checking accounts and Super NOW accounts Its loan segment portfolio consists of Residential Mortgage; Construction, Commercial, and Other Mortgage Loans; Home Equity loans & line of credit; and Consumer & others.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).